Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.
About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.
A runner completed the London Marathon and the Great North Run after undergoing years of surgery and treatment for a fractured knee.
The support is crucial for Medicare beneficiaries to gain access to healthcare innovations soon after FDA approval.
NeuroOne will get $3 million upfront for an exclusive license to distribute its radiofrequency ablation system designed to treat neurological disorders such as epilepsy and Parkinson's disease.